Results
2304
All the companies in the healthcare sector, including healthcare provider and equipment, healthcare tech, pharmaceuticals, biotech and life sciences.
2304 companies
Outset Medical
Market Cap: US$329.6m
A medical technology company, engages in the development of a hemodialysis system for hemodialysis in the United States.
OM
US$18.47
7D
-5.5%
1Y
-69.1%
Arcturus Therapeutics Holdings
Market Cap: US$329.5m
Engages in the development of infectious disease vaccines and other products within liver and respiratory rare diseases.
ARCT
US$12.80
7D
10.0%
1Y
-59.0%
CytomX Therapeutics
Market Cap: US$321.4m
Operates as an oncology-focused biopharmaceutical company that focuses on developing novel conditionally activated biologics localized to the tumor microenvironment.
CTMX
US$2.13
7D
6.5%
1Y
16.4%
Varex Imaging
Market Cap: US$317.2m
Designs, manufactures, and sells X-ray imaging components.
VREX
US$7.73
7D
-2.0%
1Y
-47.3%
iTeos Therapeutics
Market Cap: US$314.6m
A clinical-stage biopharmaceutical company, engages in the discovery and development of immuno-oncology therapeutics for patients with cancer.
ITOS
US$8.69
7D
9.0%
1Y
-50.5%
Cytek Biosciences
Market Cap: US$314.1m
A cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications.
CTKB
US$2.45
7D
-8.6%
1Y
-58.6%
Abeona Therapeutics
Market Cap: US$313.0m
A clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening diseases.
ABEO
US$6.58
7D
13.6%
1Y
57.8%
Cryoport
Market Cap: US$307.8m
Provides temperature-controlled supply chain solutions in biopharma/pharma, animal health, and reproductive medicine markets worldwide.
CYRX
US$6.22
7D
-7.6%
1Y
-42.6%
Tvardi Therapeutics
Market Cap: US$306.3m
Operates as a biotechnology company that develops medicines for cancer, chronic inflammation diseases, and fibrosis diseases.
TVRD
US$32.88
7D
22.8%
1Y
n/a
National Research
Market Cap: US$305.1m
Provides analytics and insights that facilitate measurement and improvement of the patient and employee experience.
NRC
US$13.79
7D
-1.4%
1Y
-54.4%
Cresco Labs
Market Cap: CA$417.6m
Cresco Labs Inc. cultivates, manufactures, and sells retail and medical cannabis products in the United States.
CL
CA$0.95
7D
-5.9%
1Y
-64.0%
XOMA Royalty
Market Cap: US$300.6m
Operates as a biotech royalty aggregator in the United States and the Asia Pacific.
XOMA
US$25.11
7D
-6.7%
1Y
0.1%
Aura Biosciences
Market Cap: US$299.6m
A clinical-stage biotechnology company, develops precision therapies to treat solid tumors.
AURA
US$5.94
7D
14.7%
1Y
-19.1%
Pacific Biosciences of California
Market Cap: US$294.4m
Designs, develops, and manufactures sequencing solution to resolve genetically complex problems.
PACB
US$0.94
7D
-11.2%
1Y
-51.5%
Heron Therapeutics
Market Cap: US$286.8m
A commercial-stage biotechnology company, engages in developing and commercializing therapeutic that enhances medical care.
HRTX
US$1.87
7D
0%
1Y
-46.1%
American Oncology Network
Market Cap: US$286.7m
Through its subsidiaries, provides oncology management services in the United States.
AONC
US$6.10
7D
-12.7%
1Y
186.4%
Aurora Cannabis
Market Cap: CA$395.7m
Engages in the production, distribution, and sale of cannabis and cannabis-derivative products in Canada and internationally.
ACB
CA$7.61
7D
10.1%
1Y
-13.9%
Compass Therapeutics
Market Cap: US$284.9m
A clinical-stage oncology-focused biopharmaceutical company, engages in the development of antibody-based therapeutics for the treatment of various human diseases in the United States.
CMPX
US$2.10
7D
4.0%
1Y
40.5%
Canopy Growth
Market Cap: CA$392.3m
Engages in the production, distribution, and sale of cannabis and hemp-based products for recreational and medical purposes primarily in the United States, Canada, Germany, and internationally.
WEED
CA$2.69
7D
42.3%
1Y
-78.5%
Corvus Pharmaceuticals
Market Cap: US$279.9m
A clinical stage biopharmaceutical company, engages in the development of product candidates that precisely target proteins that are critical to immune cell maturation and function in the United States.
CRVS
US$3.47
7D
-3.1%
1Y
67.6%
Imricor Medical Systems
Market Cap: AU$434.4m
A medical device company, designs, manufactures, sells, and distributes magnetic resonance imaging (MRI) compatible products for cardiac catheter ablation procedures in the United States, Europe, and the Middle East.
IMR
AU$1.56
7D
-5.5%
1Y
249.4%
Immutep
Market Cap: AU$430.8m
A late-stage biotechnology company, engages in developing novel LAG-3 related immunotherapies for cancer and autoimmune diseases in Australia.
IMM
AU$0.29
7D
-3.3%
1Y
-33.7%
Sanara MedTech
Market Cap: US$275.7m
A medical technology company, develops, markets, and distributes surgical, wound, and skincare products and services to physicians, hospitals, clinics, and post-acute care settings in the United States.
SMTI
US$30.99
7D
0.4%
1Y
7.6%
Candel Therapeutics
Market Cap: US$274.1m
A clinical stage biopharmaceutical company, develops immunotherapies for the cancer patients.
CADL
US$5.42
7D
6.1%
1Y
-49.3%
Oceania Healthcare
Market Cap: NZ$463.5m
Owns and operates various care centers and retirement villages in New Zealand.
OCA
NZ$0.66
7D
1.5%
1Y
13.8%
Panamera Holdings
Market Cap: US$273.1m
Does not have significant operations.
PHCI
US$4.00
7D
-33.3%
1Y
300.0%
Phathom Pharmaceuticals
Market Cap: US$271.6m
A biopharmaceutical company, focuses on developing and commercializing treatments for gastrointestinal diseases.
PHAT
US$4.23
7D
21.6%
1Y
-58.9%
Entrada Therapeutics
Market Cap: US$271.1m
A clinical-stage biotechnology company, develops endosomal escape vehicle (EEV) therapeutics for the treatment of multiple neuromuscular diseases.
TRDA
US$7.62
7D
-6.2%
1Y
-49.3%
Quantum-Si
Market Cap: US$270.7m
A life sciences company, engages in the development of single-molecule detection platform to enable Next Generation Protein Sequencing (NGPS).
QSI
US$1.74
7D
17.6%
1Y
4.8%
EBR Systems
Market Cap: AU$417.6m
Develops implantable systems for wireless tissue stimulation.
EBR
AU$1.21
7D
9.0%
1Y
18.0%
SANUWAVE Health
Market Cap: US$266.7m
Operates as a medical device company in the United States and internationally.
SNWV
US$28.87
7D
-7.8%
1Y
313.9%
Neuronetics
Market Cap: US$263.9m
Engages in providing in office treatments for patients with neurohealth disorders in the United States and internationally.
STIM
US$3.99
7D
-7.2%
1Y
73.5%
Viemed Healthcare
Market Cap: US$263.6m
Through its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services in the United States.
VMD
US$6.52
7D
-3.3%
1Y
-5.5%
Alpha Tau Medical
Market Cap: US$263.5m
A clinical-stage oncology therapeutics company, focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer.
DRTS
US$3.00
7D
1.4%
1Y
13.2%
Alumis
Market Cap: US$263.3m
A clinical stage biopharmaceutical company, focuses on the development and commercialization of medicines for autoimmune disorders.
ALMS
US$4.84
7D
-9.5%
1Y
n/a
Terns Pharmaceuticals
Market Cap: US$261.6m
A clinical-stage biopharmaceutical company, develops small-molecule product candidates for the treatment of oncology and obesity.
TERN
US$2.94
7D
5.4%
1Y
-49.8%